The burden of falciparum malaria remains as great as ever, and, as has probably always been the case, it is carried mainly by tropical Africa. Of the various means available for the control of malaria, the use of effective drugs remains the most important and is likely to remain so for a considerable time to come.
And what would that 'effective drug' be?
Lapdap - The outcome of a successful partnership between GlaxoSmithKline and The University of Liverpool - Coincidently where Sir Alisdair Breckenridge was Professor of Clinical Pharmacology.
Alisdair Breckenridge is currently Chairman of the MHRA. The regulator that 'regulates' the drugs you and I take.
He has also robustly denied that there is a problem with GlaxoSmithKline's antidepressant Seroxat.
(Note: You can view every article as one long page if you sign up as an Advocate Member, or higher).